Pacific Biosciences of California, Inc. (PACB) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
PACB Insider Trading Activity
PACB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,147,201 | 12 | 100 |
Related Transactions
| Kim Susan G. | See Remarks | 0 | $0 | 1 | $34,065 | $-34,065 |
| Eidel Jeff | See Remarks | 0 | $0 | 1 | $42,602 | $-42,602 |
| Farmer Michele | See Remarks | 0 | $0 | 3 | $60,619 | $-60,619 |
| Van Oene Mark | See Remarks | 0 | $0 | 4 | $331,532 | $-331,532 |
| HENRY CHRISTIAN O | See Remarks | 0 | $0 | 3 | $678,384 | $-678,384 |
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Insider Activity of Pacific Biosciences of California, Inc.
Over the last 12 months, insiders at Pacific Biosciences of California, Inc. have bought $0 and sold $1.15M worth of Pacific Biosciences of California, Inc. stock.
On average, over the past 5 years, insiders at Pacific Biosciences of California, Inc. have bought $176,160 and sold $48.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 40,000 shares for transaction amount of $176,160 was made by Meline David W (director) on 2024‑03‑06.
List of Insider Buy and Sell Transactions, Pacific Biosciences of California, Inc.
| 2025-03-03 | Sale | HENRY CHRISTIAN O | See Remarks | 12,497 0.0049% | $1.41 | $17,583 | -9.09% | |
| 2025-03-03 | Sale | Van Oene Mark | See Remarks | 6,486 0.0025% | $1.41 | $9,126 | -9.09% | |
| 2025-03-03 | Sale | Farmer Michele | See Remarks | 2,973 0.0012% | $1.41 | $4,183 | -9.09% | |
| 2025-02-18 | Sale | HENRY CHRISTIAN O | See Remarks | 259,909 0.0963% | $1.88 | $488,109 | -33.69% | |
| 2025-02-18 | Sale | Van Oene Mark | See Remarks | 100,773 0.0374% | $1.88 | $189,252 | -33.69% | |
| 2025-02-18 | Sale | Farmer Michele | See Remarks | 24,349 0.009% | $1.88 | $45,727 | -33.69% | |
| 2025-01-10 | Sale | Van Oene Mark | See Remarks | 34,405 0.0121% | $2.03 | $69,980 | -37.14% | |
| 2024-09-30 | Sale | Kim Susan G. | See Remarks | 19,782 0.0072% | $1.72 | $34,065 | -3.53% | |
| 2024-09-16 | Sale | HENRY CHRISTIAN O | See Remarks | 98,907 0.0343% | $1.75 | $172,692 | -10.81% | |
| 2024-08-19 | Sale | Eidel Jeff | See Remarks | 26,760 0.0098% | $1.59 | $42,602 | +2.50% | |
| 2024-08-16 | Sale | Van Oene Mark | See Remarks | 38,011 0.0162% | $1.66 | $63,174 | +5.13% | |
| 2024-05-20 | Sale | Farmer Michele | See Remarks | 5,275 0.002% | $2.03 | $10,708 | -13.54% | |
| 2024-03-06 | Meline David W | director | 40,000 0.0158% | $4.40 | $176,160 | -56.94% | ||
| 2024-03-04 | Sale | HENRY CHRISTIAN O | See Remarks | 14,177 0.0053% | $4.87 | $69,056 | -63.11% | |
| 2024-03-04 | Sale | Van Oene Mark | See Remarks | 9,186 0.0034% | $4.87 | $44,745 | -63.11% | |
| 2024-03-04 | Sale | Kim Susan G. | See Remarks | 5,275 0.002% | $4.87 | $25,695 | -63.11% | |
| 2024-03-04 | Sale | Farmer Michele | See Remarks | 2,968 0.0011% | $4.87 | $14,457 | -63.11% | |
| 2024-02-20 | Sale | HENRY CHRISTIAN O | See Remarks | 1,979 0.0007% | $5.26 | $10,412 | -65.41% | |
| 2024-02-20 | Sale | Kim Susan G. | See Remarks | 831 0.0003% | $5.26 | $4,372 | -65.41% | |
| 2024-02-16 | Sale | HENRY CHRISTIAN O | See Remarks | 79,038 0.0307% | $5.96 | $470,908 | -68.12% |
Insider Historical Profitability
| HENRY CHRISTIAN O | See Remarks | 2225357 0.7416% | $2.45M | 0 | 15 | |
| Van Oene Mark | See Remarks | 1497695 0.4991% | $1.65M | 0 | 11 | |
| Eidel Jeff | See Remarks | 869730 0.2898% | $956,703.00 | 0 | 3 | |
| Kim Susan G. | See Remarks | 695654 0.2318% | $765,219.40 | 0 | 10 | |
| Farmer Michele | See Remarks | 184619 0.0615% | $203,080.90 | 0 | 8 | |
| Turner Stephen W | VP & Chief Technology Officer | 1025163 0.3416% | $1.13M | 0 | 3 | |
| BARNES SUSAN K | EVP, CFO and PAO | 874812 0.2915% | $962,293.20 | 0 | 2 | |
| Hunkapiller Michael | director | 848405 0.2827% | $933,245.50 | 20 | 28 | +56.73% |
| Phillips James Michael | SVP, Research & Development | 249220 0.083% | $274,142.00 | 8 | 7 | +10.38% |
| Fromen Peter | Chief Commercial Officer | 140280 0.0467% | $154,308.00 | 0 | 1 | |
| Schaefer Eric | Chief Accounting Officer | 88474 0.0295% | $97,321.40 | 0 | 1 | |
| CORCORAN KEVIN P | SVP, Market Development | 40455 0.0135% | $44,500.50 | 3 | 0 | <0.0001% |
| Meline David W | director | 40000 0.0133% | $44,000.00 | 1 | 0 | <0.0001% |
| Ericson William W. | director | 18795 0.0063% | $20,674.50 | 12 | 2 | +17.15% |
| ORDONEZ KATHY | director | 18595 0.0062% | $20,454.50 | 0 | 4 | |
| Dow Brian B | VP and PAO | 18119 0.006% | $19,930.90 | 1 | 0 | <0.0001% |
| LIVINGSTON RANDALL S | director | 0 0% | $0 | 0 | 1 | |
| Shapiro Lucy | director | 0 0% | $0 | 0 | 1 | |
| Botstein David | director | 0 0% | $0 | 0 | 1 |
PACB Institutional Investors: Active Positions
| Increased Positions | 116 | +42.49% | 48M | +20.61% |
| Decreased Positions | 112 | -41.03% | 27M | -11.76% |
| New Positions | 41 | New | 29M | New |
| Sold Out Positions | 44 | Sold Out | 9M | Sold Out |
| Total Postitions | 277 | +1.47% | 252M | +8.86% |
PACB Ownership Change vs Market
Institutional Investor Ownership
| Ark Investment Management Llc | $40,730.00 | 12.02% | 36.04M | +3M | +7.9% | 2024-12-31 |
| Blackrock, Inc. | $26,504.00 | 7.82% | 23.46M | -1M | -4.63% | 2025-03-31 |
| Madrone Advisors, Llc | $26,433.00 | 7.8% | 23.39M | 0 | 0% | 2024-12-31 |
| Edmond De Rothschild Holding S.A. | $24,122.00 | 7.12% | 21.35M | +1M | +5.11% | 2024-12-31 |
| Softbank Group Corp. | $23,110.00 | 6.82% | 20.45M | +20M | New | 2024-12-31 |
| Millennium Management Llc | $19,284.00 | 5.69% | 17.07M | +7M | +63.73% | 2024-12-31 |
| Vanguard Group Inc | $17,206.00 | 5.08% | 15.23M | -2M | -13.69% | 2024-12-31 |
| Nikko Asset Management Americas, Inc. | $11,502.00 | 3.39% | 10.18M | -2M | -14.22% | 2024-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | $10,809.00 | 3.19% | 9.57M | -613,170 | -6.02% | 2025-03-31 |
| State Street Corp | $7,262.00 | 2.14% | 6.43M | +150,819 | +2.4% | 2024-12-31 |